Over 12 months, CG Oncology, Inc. saw more buying than selling from its insiders — purchases of about $24.8 million against sales of $4.8 million.
Liu Brian Guan-Chyun (Director) made the biggest buy, worth around $24.8 million.
Looking at the quarterly pattern: Last full quarter: net selling by insiders. Insiders bought in 2 of the last 7 full quarters. 227 investment managers listed CGON in their latest 13F filings (Q2 2026); more funds bought than sold.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | POST LEONARD E | Director | Sell | 1,000 | $72.98 | $73K | SEC |
| Aug 18, 2026 | POST LEONARD E | Director | Sell | 1,000 | $74.54 | $75K | SEC |
| Jul 17, 2026 | POST LEONARD E | Director | Sell | 1,000 | $71.17 | $71K | SEC |
| Jul 14, 2026 | Mulay James | Director | Sell | 24,165 | $75.16 | $1.8M | SEC |
| Jun 29, 2026 | Liu Brian Guan-Chyun | Director | Buy | 371,085 | $66.87 | $24.8M | SEC |
| Jun 25, 2026 | POST LEONARD E | Director | Sell | 5,000 | $70.00 | $350K | SEC |
| Jun 23, 2026 | POST LEONARD E | Director | Sell | 5,000 | $65.00 | $325K | SEC |
| Jun 16, 2026 | Mulay James | Director | Sell | 1,310 | $60.12 | $79K | SEC |
| Jun 16, 2026 | Mulay James | Director | Sell | 654 | $60.12 | $39K | SEC |
| Jun 5, 2026 | POST LEONARD E | Director | Sell | 1,000 | $54.50 | $54K | SEC |
| Apr 20, 2026 | Mulay James | Director | Sell | 15,600 | $73.01 | $1.1M | SEC |
| Mar 17, 2026 | Mulay James | Director | Sell | 654 | $63.50 | $42K | SEC |
| Mar 17, 2026 | Mulay James | Director | Sell | 1,310 | $63.50 | $83K | SEC |
| Jan 13, 2026 | Mulay James | Director | Sell | 10,491 | $52.99 | $556K | SEC |
| Jan 13, 2026 | Mulay James | Director | Sell | 654 | $44.16 | $29K | SEC |
In the last 12 months CG Oncology, Inc. insiders made open-market purchases worth about $24.8 million and sales worth about $4.8 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in CGON was filed on 2026-09-17.
227 investment managers reported holding CGON in SEC Form 13F filings for Q2 2026.
No congressional trades in CGON were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).